Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
Shenzhen Stock ExchangeTotal Valuation
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. carries a market capitalization of 2.84B, placing it among publicly traded companies globally. Its enterprise value stands at 3.09B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.84B |
| Enterprise Value | 3.09B |
Share Statistics
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. currently has 234.45M shares outstanding.
| Shares Outstanding | 234.45M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. trades at a trailing price-to-earnings ratio of 25.71. The price-to-sales ratio is 4.82, and the price-to-book ratio stands at 4.10.
| PE Ratio | 25.71 |
| PS Ratio | 4.82 |
| PB Ratio | 4.10 |
| P/TBV Ratio | 3.30 |
| P/FCF Ratio | 114.13 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. trades at an EV/EBITDA multiple of 20.14 and an EV/FCF ratio of 75.07. The EV/Sales ratio of 4.23 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 20.14 provides insight into valuation relative to core operating earnings.
| EV / Sales | 4.23 |
| EV / EBITDA | 20.14 |
| EV / EBIT | 20.14 |
| EV / FCF | 75.07 |
Financial Position
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. maintains a current ratio of 4.39, meaning it holds 4.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 29.53, indicating elevated leverage, while an interest coverage ratio of 15.29 demonstrates strong ability to service its debt obligations.
| Current Ratio | 4.39 |
| Quick Ratio | 3.03 |
| Debt / Equity | 29.53 |
| Debt / EBITDA | 2.16 |
| Interest Coverage | 15.29 |
Financial Efficiency
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. posts a return on equity of 16.81 and a return on invested capital of 9.46.
| Return on Equity (ROE) | 16.81 |
| Return on Assets (ROA) | 8.18 |
| Return on Invested Capital (ROIC) | 9.46 |
| Return on Capital Employed (ROCE) | 12.25 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 5.79 |
Taxes
Over the trailing twelve months, Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. has paid 20.50M in income taxes, reflecting an effective tax rate of 13.21.
| Income Tax | 20.50M |
| Effective Tax Rate | 13.21 |
Stock Price Statistics
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.'s stock has declined approximately -14.93689% over the past 52 weeks. The 50-day moving average sits at 12.86, while the 200-day moving average is 14.03.
| Beta (5Y) | N/A |
| 52-Week Price Change | -14.93689% |
| 50-Day Moving Average | 12.86 |
| 200-Day Moving Average | 14.03 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. generated 730.65M in revenue and converted that into 136.91M in net income, yielding earnings per share of 0.54. EBITDA reached 153.45M, while operating income came in at 153.45M.
| Revenue | 730.65M |
| Gross Profit | 233.71M |
| Operating Income | 153.45M |
| Pretax Income | 155.19M |
| Net Income | 136.91M |
| EBITDA | 153.45M |
| EBIT | 153.45M |
| Earnings Per Share (EPS) | 0.54 |
Balance Sheet
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. holds 827.94M in cash and equivalents against 331.42M in total debt, resulting in a net debt position of 61.92M. Total book value stands at 858.95M, with working capital of 927.97M providing operational flexibility.
| Cash & Cash Equivalents | 827.94M |
| Total Debt | 331.42M |
| Net Debt | 61.92M |
| Equity (Book Value) | 858.95M |
| Book Value Per Share | 3.65 |
| Working Capital | 927.97M |
Cash Flow
After subtracting -32.47M in capital expenditures, free cash flow totaled -32.47M - equivalent to -0.14 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -32.47M |
| Free Cash Flow | -32.47M |
| FCF Per Share | -0.14 |
Margins
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. operates with a gross margin of 31.99, reflecting its pricing power and cost economics. The operating margin of 21.00 and net profit margin of 18.74 provide insight into operational efficiency.
| Gross Margin | 31.99 |
| Operating Margin | 21.00 |
| Pretax Margin | 21.24 |
| Profit Margin | 18.74 |
| EBITDA Margin | 21.00 |
Dividends & Yields
The company's payout ratio of 53.91 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.30 |
| Dividend Yield | N/A |
| Payout Ratio | 53.91 |
| Shareholder Yield | 1.76 |
| FCF Yield | 0.88 |
Stock Splits
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.'s most recent stock split took place on May 26, 2022 with a 10:13 split ratio.
| Last Split Date | 5/26/2022 |
| Split Ratio | 10:13 |
Scores
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. posts an Altman Z-Score of 5.22, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.22 |